The FDA Has Accepted Us Marketing Application For GSK's Gepotidacin, An Oral Antibiotic For Adult And Adolescent Females For Uncomplicated Urinary Tract Infections, 26 March 2025 Assigned As Action Date For FDA Decision

Benzinga · 10/16 10:37
  • Gepotidacin could be the first in a new class of oral antibiotic treatment for uUTIs in over 20 years.
  • Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials.